Senior insider sale
Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.06M
1.96K shares
What this filing means
HUNTSMAN CAROLE plans to sell 1.96K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/21/2025ACC: 0001628280-25-053607
Officer· Chief Commercial Officer
Since Mar 2026
1.96K
Shares to sell
$1.06M
Approx. market value
1.96K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
11/20/2025
1.06KRestricted Stock Unit Grant
Vesting of Restricted Stock Units
11/20/2025
894.00Total acquired1.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/20/2025 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 1.06K | — |
11/20/2025 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 894.00 | — |
| Total | 1.96K | ||
Planned & Completed Dispositions2
Nasdaq Stock MarketPlanned
Units to sell
894.00
Market value
$484.7K
11/21/2025
Nasdaq Stock MarketPlanned
Units to sell
1.06K
Market value
$576.8K
11/21/2025
Total
Units
1.96K
Value
$1.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/21/2025 | 894.00 | $484.7K | Nasdaq Stock Market | Planned |
11/21/2025 | 1.06K | $576.8K | Nasdaq Stock Market | Planned |
| Total | 1.96K | $1.06M | ||